SCHEMBL2135261

SCHEMBL2135261

CCN[C@H](CC)C(=O)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
CTSK P43235 3/20 0.49
TACR1 P25103 1/20 0.47
KMT2A Q03164 2/20 0.46
MAPK1 P28482 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
TRPM8 Q7Z2W7 1/20 0.45
POLB P06746 1/20 0.45
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
SYK P43405 1/20 0.44
GAA P10253 1/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
ACE P12821 1/20 0.43
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2135267 1.00 ALDH1A1 (0.51) ALDH1A1CTSKTACR1KMT2AMAPK1
SCHEMBL2137673 1.00 ALDH1A1 (0.51) ALDH1A1CTSKTACR1KMT2AMAPK1
SCHEMBL12406830 0.89 ALDH1A1 (0.50) ALDH1A1CTSKTACR1KMT2AMAPK1
SCHEMBL13936584 0.89 ALDH1A1 (0.50) ALDH1A1CTSKTACR1KMT2AMAPK1
SCHEMBL23104412 0.89 ALDH1A1 (0.50) ALDH1A1CTSKTACR1KMT2AMAPK1
SCHEMBL23114754 0.89 ALDH1A1 (0.50) ALDH1A1CTSKTACR1KMT2AMAPK1
SCHEMBL20394526 0.89 TACR1 (0.56) ALDH1A1CTSKTACR1TRPM8POLB
SCHEMBL23104759 0.89 ALDH1A1 (0.50) ALDH1A1CTSKTACR1KMT2AMAPK1
SCHEMBL20394525 0.89 TACR1 (0.56) ALDH1A1CTSKTACR1TRPM8POLB
SCHEMBL2137853 0.88 CTSK (0.51) ALDH1A1CTSKTACR1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2447265-A1 NOVEL THIOPHENE CARBOXAMIDE DERIVATIVE AND MEDICINAL USE OF SAME Sanwa Kagaku Kenkyusho Co., Ltd (JP) 2012-05-02 EP disclosed
US-20120101137-A1 NOVEL THIOPHENECARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 2012-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101137-A1 NOVEL THIOPHENECARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF GCK, GCKR, HK2 ALDH1A1 2623/4885CTSK 618/4885TACR1 2122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.